Hepatocyte nuclear factor 1β suppresses canonical Wnt signaling through transcriptional repression of lymphoid enhancer-binding factor 1

被引:5
|
作者
Chan, Siu Chiu [1 ]
Hajarnis, Sachin S. [2 ,3 ]
Vrba, Sophia M. [1 ,4 ]
Patel, Vishal [2 ]
Igarashi, Peter [1 ,2 ]
机构
[1] Univ Minnesota, Sch Med, Dept Med, Minneapolis, MN 55455 USA
[2] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA
[3] Otsuka Pharmaceut Dev & Commercializat Inc, Princeton, NJ USA
[4] NIAID, Lab Clin Immunol & Microbiol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA
基金
美国国家卫生研究院;
关键词
HNF-1β β -catenin; LEF1; kidney; histone methylation; tissue-specific transcription factor; Wnt pathway; beta-catenin (B-catenin); transcription repressor; T-cell factor (TCF); cystic kidney disease; WNT/BETA-CATENIN; KIDNEY DEVELOPMENT; GENE-EXPRESSION; RENAL CYSTS; FACTOR-I; HNF-1-BETA; ACTIVATION; DISEASE; MECHANISMS; COMPONENTS;
D O I
10.1074/jbc.RA120.015592
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hepatocyte nuclear factor-1 beta (HNF-1 beta) is a tissue-specific transcription factor that is required for normal kidney development and renal epithelial differentiation. Mutations of HNF-1 beta produce congenital kidney abnormalities and inherited renal tubulopathies. Here, we show that ablation of HNF-1 beta in mIMCD3 renal epithelial cells results in activation of beta-catenin and increased expression of lymphoid enhancer-binding factor 1 (LEF1), a downstream effector in the canonical Wnt signaling pathway. Increased expression and nuclear localization of LEF1 are also observed in cystic kidneys from Hnf1b mutant mice. Expression of dominant-negative mutant HNF-1 beta in mIMCD3 cells produces hyperresponsiveness to exogenous Wnt ligands, which is inhibited by siRNA-mediated knockdown of Lef1. WT HNF-1 beta binds to two evolutionarily conserved sites located 94 and 30 kb from the mouse Lef1 promoter. Ablation of HNF-1 beta decreases H3K27 trimethylation repressive marks and increases beta-catenin occupancy at a site 4 kb upstream to Lef1. Mechanistically, WT HNF-1 beta recruits the polycomb-repressive complex 2 that catalyzes H3K27 trimethylation. Deletion of the beta-catenin-binding domain of LEF1 in HNF-1 beta-deficient cells abolishes the increase in Lef1 transcription and decreases the expression of downstream Wnt target genes. The canonical Wnt target gene, Axin2, is also a direct transcriptional target of HNF-1 beta through binding to negative regulatory elements in the gene promoter. These findings demonstrate that HNF-1 beta regulates canonical Wnt target genes through long-range effects on histone methylation at Wnt enhancers and reveal a new mode of active transcriptional repression by HNF-1 beta.
引用
收藏
页码:17560 / 17572
页数:13
相关论文
共 50 条
  • [1] Hepatocyte nuclear factor-1β regulates Wnt signaling through genome-wide competition with β-catenin/lymphoid enhancer binding factor
    Chan, Siu Chiu
    Zhang, Ying
    Pontoglio, Marco
    Igarashi, Peter
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2019, 116 (48) : 24133 - 24142
  • [2] Aberrant expression of lymphoid enhancer-binding factor 1 in Hodgkin lymphoma
    Ravindran, Aishwarya
    Kurtin, Paul J.
    King, Rebecca L.
    Yuan, Ji
    Feldman, Andrew L.
    Rech, Karen L.
    McPhail, Ellen D.
    Parikh, Sameer A.
    Ding, Wei
    Shi, Min
    HUMAN PATHOLOGY, 2022, 125 : 2 - 10
  • [3] Expression of lymphoid enhancer-binding factor 1 in breast fibroepithelial lesions
    Chen, Po-Han
    Bossuyt, Veerle
    Reisenbichler, Emily
    HUMAN PATHOLOGY, 2021, 108 : 68 - 75
  • [4] LYMPHOID ENHANCER-BINDING FACTOR 1 (LEF1): AN IMMUNOHISTOCHEMICAL PREDICTIVE MARKER FOR WNT-ACTIVATED MEDULLOBLASTOMA
    Ranade, Manali
    Naik, Khushi
    Bapat, Prachi
    Gurav, Mamta
    Shetty, Omshree
    Shah, Aekta
    Sahay, Ayushi
    Prasad, Maya
    Singh, Vikash
    Shetty, Prakash
    Moiyadi, Aliasgar
    Dasgupta, Archya
    Chatterjee, Abhishek
    Chinnaswamy, Girish
    Gupta, Tejpal
    Epari, Sridhar
    NEURO-ONCOLOGY, 2024, 26
  • [5] Immunohistochemical Expression of Lymphoid Enhancer-Binding Factor 1 in Endometrial Stromal Tumors
    Lu, Haiyan
    Li, Wencheng
    Hou, Yanjun
    LABORATORY INVESTIGATION, 2023, 103 (03) : S943 - S944
  • [6] Eyelid sebaceous carcinoma: a novel mutation in lymphoid enhancer-binding factor-1
    Jayaraj, P.
    Sen, S.
    Sharma, A.
    Chosdol, K.
    Kashyap, S.
    Rai, A.
    Pushker, N.
    Bajaj, M.
    BRITISH JOURNAL OF DERMATOLOGY, 2015, 173 (03) : 811 - 814
  • [7] Clinical significance of lymphoid enhancer-binding factor 1 expression in acute myeloid leukemia
    Fu, Yuan
    Zhu, Huayuan
    Wu, Wei
    Xu, Jiadai
    Chen, Tingmei
    Xu, Bei
    Qian, Sixuan
    Li, Jianyong
    Liu, Peng
    LEUKEMIA & LYMPHOMA, 2014, 55 (02) : 371 - 377
  • [8] Lymphoid Enhancer-Binding Factor 1 is Upregulated in Adenocarcinomas of Gynecologic and Non-Gynecologic Origin
    Salinas, E.
    Neff, T.
    Park, S.
    Goodheart, M.
    GYNECOLOGIC ONCOLOGY, 2016, 143 (01) : 218 - 219
  • [9] Overexpression of Lymphoid Enhancer-Binding Factor 1 (LEF1) in solid-pseudopapillary neoplasms of the pancreas
    Singhi, Aatur D.
    Lilo, Mhammed
    Hruban, Ralph H.
    Cressman, Kristi L.
    Fuhrer, Kimberly
    Seethala, Raja R.
    MODERN PATHOLOGY, 2014, 27 (10) : 1355 - 1363
  • [10] Lymphoid enhancer-binding factor 1 (LEF-1): a favorable prognostic factor in adult acute myeloid leukemia in Egyptian patients
    Farweez, Botheina Ahmed Thabet
    Shalaby, Nahela Ahmed
    Eissa, Doaa Ahmed Gamal
    Galal, Raghda El Sayed Abdel Monem
    El-khazragy, Nashwa
    Pessar, Shaimaa Abdelmalik
    EGYPTIAN JOURNAL OF MEDICAL HUMAN GENETICS, 2020, 21 (01)